Business

Q2 2026 Results Date Confirmed - 28 July 2026

GSK plc has announced that its Q2 2026 results will be published on Tuesday, 28 July 2026, and will include an update on portfolio growth opportunities. The company also provided indicative dates for its Q3 2026 results on Wednesday, 28 October 2026, and Q4 2026 results on Wednesday, 3 February 2027, along with associated ex-dividend, record, and payment dates for ordinary shares and American Depositary Shares for the remainder of the financial year. Disclaimer*

articleGsk PlcMay 22, 20264/company/glaxosmithkline-plc/news/q2-2026-results-date-confirmed-28-july-2026
Q2 2026 Results Date Confirmed - 28 July 2026

About this update from Gsk Plc

[{"type":"text","content":"\n\nGSK plc\n \nGSK confirms that the Company's Q2 2026 results are due to be published via the London Stock Exchange on Tuesday 28 July 2026. GSK will also provide an update on portfolio growth opportunities.\n \nThe results announcement dates and respective record and dividend dates for the remainder of the financial year are set out below:\n \n\n\n\n\nResults\n\n\nAnnouncement date\n\n\nOrdinary Shares Ex-dividend date\n\n\nAmerican Depositary Shares Ex-dividend date\n\n\nRecord date\n\n\nLast date for DRIP elections\n\n\nPayable\n\n\n\n\nQ2 2026\n\n\nTuesday 28 July 2026\n\n\nThursday 13 August 2026\n\n\n \nFriday 14 August 2026\n \n\n\nFriday 14 August 2026\n\n\nThursday 17 September 2026\n\n\nThursday 8 October 2026\n\n\n\n\nQ3 2026\n\n\n \nWednesday 28 October 2026\n \n\n\nThursday 12 November 2026\n\n\nFriday 13 November 2026\n\n\nFriday 13 November 2026\n\n\nMonday 14 December 2026\n\n\nThursday 7 January 2027\n\n\n\n\nQ4 2026\n\n\n \nWednesday 3 February 2027\n \n\n\nThursday 18 February 2027\n\n\nFriday 19 February 2027\n\n\nFriday 19 February 2027\n\n\nTuesday 16 March 2027\n\n\nThursday 8 April 2027\n\n\n\n\n \nThese dates are indicative and may be subject to change.  \n \n \nV A Whyte\nCompany Secretary\n \n22 May 2026\n \n \n\n","length":5688,"tagName":"div"}]

More updates from Gsk Plc